Exploratory Studies With BT-11: A Proposed Orally Active Therapeutic for Crohn's Disease.
Bissel P, Boes K, Hinckley J, Jortner BS, Magnin-Bissel G, Werre SR, Ehrich M, Carbo A, Philipson C, Hontecillas R, Philipson N, Gandour RD, Bassaganya-Riera J.
Bissel P, et al. Among authors: ehrich m.
Int J Toxicol. 2016 Sep;35(5):521-9. doi: 10.1177/1091581816646356. Epub 2016 May 26.
Int J Toxicol. 2016.
PMID: 27230993
Free PMC article.